Neurological Biomarkers Market Research Report 2023-2028

IMARC Group has recently released a new research study titled “Neurological Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.

How Big is the Neurological Biomarkers Market?

Global neurological biomarkers market size has reached a staggering US$ 7.9 Billion in 2022. IMARC Group expects the market to grow further, reaching US$ 16.4 Billion by 2028, with a CAGR of 13.1% during 2023-2028.

What is the Neurological Biomarkers?

Neurological biomarkers refer to the biomarkers that are considered standards for calculating and assessing a symptom or method for attaining a pharmacological response to a precise treatment. They are present in the cerebral spinal fluid (CSF), but rarely at undetectable levels in the blood. The key sources of these biomarkers are genetic mutations, metabolite levels, brain imaging and changes in protein expression or post-translational modifications. These biomarkers are widely used in clinical practice during drug development.

Get Free Sample Copy of Report at: https://www.imarcgroup.com/neurological-biomarkers-market/requestsample

Neurological Biomarkers Market Growth Drivers and Demand:

The global neurological biomarkers market is primarily being driven by the increasing prevalence of neurological diseases, including dementia, migraines, Alzheimer’s disease, epilepsy, and brain tumors. In line with this, the use of these biomarkers to evaluate the effectiveness of innovative drugs and therapeutic strategies is further contributing to the market growth. Significant technological advancements, along with the use of neurological biomarkers in non-invasive testing, early diagnosis of diseases, and faster drug development are positively influencing the growth of the market.

Apart from this, the rise in healthcare expenditure and the increasing number of clinical trials are expected to drive the market growth. Moreover, the increasing investment by key players at different stages of research and an enhanced focus on personalized medicine, coupled with the launch of novel neurological biomarkers are anticipated to create a positive outlook for the market.

Who are the key players operating in the industry?

The report covers the major market players including: 

Market Segmentation:

The report has segmented the neurological biomarkers market on the basis of type, application, end use and region.

Breakup by Type:

Breakup by Application:

Breakup by End Use:

Breakup by Region:

Speak to Analyst: https://www.imarcgroup.com/request?type=report&id=3181&flag=C

Key Highlights of the Report:           

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Who we are:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com